Fragment Screening Identifies Novel Allosteric Binders and Binding Sites in the VHR (DUSP3) Phosphatase
ACS Omega,
Journal Year:
2025,
Volume and Issue:
10(5), P. 4912 - 4926
Published: Jan. 31, 2025
The
human
Vaccinia
H1-related
phosphatase
(VHR;
DUSP3)
is
a
critical
positive
regulator
of
the
innate
immune
response.
Recent
studies
suggest
that
inhibiting
VHR
could
be
beneficial
in
treating
sepsis
and
septic
shock.
belongs
to
superfamily
protein
tyrosine
phosphatases
(PTPs),
large
class
enzymes
are
notoriously
difficult
target
with
small
molecules.
Fragment-based
drug
discovery
(FBDD)
has
emerged
as
an
effective
strategy
for
generating
potent
ligands,
even
challenging
targets.
Here,
we
present
fluorine
NMR-based
platform
identifying
fragments
bind
VHR.
This
encompasses
automated
library
assembly,
mixture
formation,
quantitative
material
transfer,
NMR
screening,
biophysical
hit
confirmation.
We
demonstrate
this
streamlined,
integrated
screening
workflow
produces
validated
hits
diverse
chemical
matter
tangible
structure-activity
relationships
(SAR).
Crystal
structures
yielded
detailed
information
on
fragment-protein
interactions
provide
basis
future
structurally
enabled
ligand
optimization.
Notably,
discovered
novel
binding
sites
VHR,
distant
from
conserved
active
site,
facilitating
generation
selective
modulators.
fragment
can
applied
other
PTPs
holds
significant
potential
ligands.
Language: Английский
Synthesis and evaluation of fluorinated tetrahydrocarbazoles as probes in NMR based binding assay of the E. coli β sliding clamp
Bioorganic & Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
122, P. 118139 - 118139
Published: Feb. 27, 2025
Language: Английский
NMR investigations of glycan conformation, dynamics, and interactions
Progress in Nuclear Magnetic Resonance Spectroscopy,
Journal Year:
2024,
Volume and Issue:
144-145, P. 97 - 152
Published: Oct. 12, 2024
Language: Английский
Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery
Molecules,
Journal Year:
2024,
Volume and Issue:
29(23), P. 5748 - 5748
Published: Dec. 5, 2024
Fragment-based
drug
discovery
is
a
powerful
approach
in
discovery,
applicable
to
wide
range
of
targets.
This
method
enables
the
potent
compounds
that
can
modulate
target
functions,
starting
from
fragment
bind
weakly
While
biochemical,
biophysical,
and
cell-based
assays
are
commonly
used
identify
fragments,
Language: Английский